This submission details research activities within UoA 10 (Dentistry), although since 2001 the Eastman Dental Institute (EDI) has had increasingly strong research collaborations with other University College London (UCL) UoAs, University College London NHS Foundation Trust (UCLHT) and with Great Ormond Street Hospital for Children.

In response to the RAE 2001 feedback and subsequent significant staff changes, EDI revised its research strategy to enhance those important research areas which were likely to produce sustainable peer reviewed research funding and high quality publication outputs, and aligned with other major research themes prominent within UCL Biomedicine. Thus dental research in UCL was refocused on three themes - Biomaterials & Tissue Engineering, Microbial Diseases and Dental Public Health - all important in contemporary and future oral health care:

  • Biomaterials & Tissue Engineering research is co-ordinated by the EDI Division of Biomaterials & Tissue Engineering (BTE) and executed mainly in this science Division and two of the clinical Divisions (see Research organisation, management and support). In response to RAE 2001, and to build upon strong outputs, staff and resources from the previous groups of Oral Biology & Pathology and Health Service Sciences & Informatics were redeployed and reinvested and strengthened by key appointments to establish this new Division.
  • Microbial Diseases research is co-ordinated by the EDI Division of Microbial Diseases (MD) and executed mainly in this science Division and two clinical Divisions. In response to RAE 2001, and to build upon strong outputs, Infection and Immunity was strengthened by key appointments to create this new Division.
  • Dental Public Health research remains the remit of UCL Dental Public Health (DPH), a unit which is within UCL Department of Epidemiology & Public Health, returned under UoA6, but with which stronger research collaborations are planned.

EDI has more latterly introduced cross-cutting themes in response to the NHS “Best Research for Health” strategy. These research areas were supported as part of the funding provided through the recent (2006) National Institute for Health Research (NIHR), Comprehensive Biomedical Research Centre (CBRC) successful bid to the Department of Health (DH). 

Since 2001, this EDI strategy has led to substantial, increased and sustained research funding, significant research findings, patents and commercial applications. The value of research grants awarded has been enhanced to £14.8 million (BTE £6.65m and MD £8.15m) with research income totalling £9.4 million including:

  • Research income from UK Research Councils exceeding £3 million
  • Five fellowships
  • Overseas research grant income which has been awarded from major International Research Funding Bodies such as National Institutes of Health [NIH] (USA) and European Union Framework Programmes 5 and 6 (the latter - £ 1.58 million).

EDI research quality and relevance were recently reviewed by the Department of Health (DH) as part of the UCL/UCLHT submission to NIHR for CBRC funding. Following a competitive national peer review process EDI secured recurrent NIHR funding for an Oral Health research programme. EDI was one of only two UK dental institutes to obtain such funding, but the £6 million over five years (£1.2 million per year) is excluded from RA4 income. The CBRC cross-thematic approach (e.g. driving research between its 17 themes) provides further opportunities for cross-fertilisation of clinically-applied research, paralleling the strong, productive and sustainable collaborations that EDI has established within UCL. 

Download full text of the RA5a statement for Dentistry (pdf 292Kb)

Staff names below link to submitted publications:

[external source element is broken]
error message: The database connection Oracle_database_connection2 cannot be found.

Page last modified on 14 jan 08 10:11